FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.8  |  FHIR Version n/a  User: [n/a]

3147611000001100: Hytrin 2mg tablets (Abbott Laboratories Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17272101000001118 Hytrin 2mg tablets (Abbott Laboratories Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17272201000001113 Hytrin 2mg tablets (Abbott Laboratories Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38161401000001118 Hytrin 2mg tablets (Amdipharm) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
54085501000001118 Hytrin 2mg tablets (Amdipharm Plc) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
78810301000001117 Hytrin 2mg tablets (AMCo) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
111545701000001114 Hytrin 2mg tablets (Advanz Pharma) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hytrin 2mg tablets (Abbott Laboratories Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Hytrin 2mg tablets (Abbott Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Hytrin 2mg tablets (Abbott Laboratories Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Hytrin 2mg tablets (Abbott Laboratories Ltd) Is a Product containing precisely terazosin (as terazosin hydrochloride) 2 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Hytrin 2mg tablets (Abbott Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Hytrin 2mg tablets (Abbott Laboratories Ltd) Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
Hytrin 2mg tablets (Abbott Laboratories Ltd) Has active ingredient Terazosin hydrochloride false Inferred relationship Existential restriction modifier
Hytrin 2mg tablets (Abbott Laboratories Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Hytrin 2mg tablets (Abbott Laboratories Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Hytrin 2mg tablets (Abbott Laboratories Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Hytrin 2mg tablets (Abbott Laboratories Ltd) Is a Hytrin true Inferred relationship Existential restriction modifier
Hytrin 2mg tablets (Abbott Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Terazosin true Inferred relationship Existential restriction modifier
Hytrin 2mg tablets (Abbott Laboratories Ltd) Has specific active ingredient Terazosin hydrochloride true Inferred relationship Existential restriction modifier
Hytrin 2mg tablets (Abbott Laboratories Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Hytrin 2mg tablets (Abbott Laboratories Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Hytrin 2mg tablets (Abbott Laboratories Ltd) Has basis of strength substance Terazosin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Hytrin 2mg tablets (Abbott Laboratories Ltd) 28 tablet 2 x 14 tablets Is pack of False Hytrin 2mg tablets (Abbott Laboratories Ltd) Inferred relationship Existential restriction modifier
Hytrin 2mg tablets (Abbott Laboratories Ltd) 21 tablet Is pack of False Hytrin 2mg tablets (Abbott Laboratories Ltd) Inferred relationship Existential restriction modifier
Hytrin 2mg tablets (Abbott Laboratories Ltd) 14 tablet Is pack of False Hytrin 2mg tablets (Abbott Laboratories Ltd) Inferred relationship Existential restriction modifier
Hytrin 2mg tablets (Abbott Laboratories Ltd) 14 tablet Has AMP True Hytrin 2mg tablets (Abbott Laboratories Ltd) Inferred relationship Existential restriction modifier
Hytrin 2mg tablets (Abbott Laboratories Ltd) 28 tablet 2 x 14 tablets Has AMP True Hytrin 2mg tablets (Abbott Laboratories Ltd) Inferred relationship Existential restriction modifier
Hytrin 2mg tablets (Abbott Laboratories Ltd) 21 tablet Has AMP True Hytrin 2mg tablets (Abbott Laboratories Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start